Terms: = Pancreatic cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
55 results:
1. hmga2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells.
Luo Z; Zheng Q; Ye S; Li Y; Chen J; Fan C; Chen J; Lei Y; Liao Q; Xi Y
Cell Death Dis; 2024 Mar; 15(3):220. PubMed ID: 38493165
[TBL] [Abstract] [Full Text] [Related]
2. Significance of High-Mobility Group A Protein 2 Expression in pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma.
Oflas D; Canaz F; Özer İ; Demir L; Çolak E
Turk J Gastroenterol; 2023 Oct; 34(10):1014-1024. PubMed ID: 37787719
[TBL] [Abstract] [Full Text] [Related]
3. cancer vaccines are back, revitalized.
Vonderheide RH
Med; 2023 Jul; 4(7):395-397. PubMed ID: 37453413
[TBL] [Abstract] [Full Text] [Related]
4. Silencing effects of mutant RAS signalling on transcriptomes.
Sers C; Schäfer R
Adv Biol Regul; 2023 Jan; 87():100936. PubMed ID: 36513579
[TBL] [Abstract] [Full Text] [Related]
5. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis.
Chen L; Zhang X; Zhang Q; Zhang T; Xie J; Wei W; Wang Y; Yu H; Zhou H
Front Immunol; 2022; 13():1022420. PubMed ID: 36275722
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract] [Full Text] [Related]
7. Structure-based discovery of a specific SHP2 inhibitor with enhanced blood-brain barrier penetration from PubChem database.
Ma Y; Li WY; Sun T; Zhang L; Lu XH; Yang B; Wang RL
Bioorg Chem; 2022 Apr; 121():105648. PubMed ID: 35180489
[TBL] [Abstract] [Full Text] [Related]
8. Long non-coding RNA ZFAS1 promotes pancreatic cancer proliferation and metastasis by sponging miR-497-5p to regulate hmga2 expression.
Rao M; Xu S; Zhang Y; Liu Y; Luan W; Zhou J
Cell Death Dis; 2021 Sep; 12(10):859. PubMed ID: 34552050
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of high mobility group A2 (hmga2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic hmga2 expression.
Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
[TBL] [Abstract] [Full Text] [Related]
10. Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy.
Wang K; Shang F; Chen D; Cao T; Wang X; Jiao J; He S; Liang X
J Nanobiotechnology; 2021 Jan; 19(1):31. PubMed ID: 33482834
[TBL] [Abstract] [Full Text] [Related]
11. Antitumor Activity of Lipid-DNA Aptamer Modified T Lymphocytes in Carcinoma.
Zhong L; Gan L; Deng Z; Liu X; Peng H; Tang H; Liu X; Fang F; Yao F; Li W; Liu Z; Hou W; Cui C; Zhao Y; Tan W; Shi W; He J
J Biomed Nanotechnol; 2020 Jul; 16(7):1110-1118. PubMed ID: 33308378
[TBL] [Abstract] [Full Text] [Related]
12. Role of miR-30a-3p Regulation of Oncogenic Targets in pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract] [Full Text] [Related]
13. High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis.
Thi-Hai Pham Y; Utuama O; Thomas CE; Park JA; La Vecchia C; Risch HA; Tran CT; Le TV; Boffetta P; Raskin L; Luu HN
Eur J Cancer Prev; 2020 Nov; 29(6):565-581. PubMed ID: 32898013
[TBL] [Abstract] [Full Text] [Related]
14. [Expression of miRNA let-7a and hmga2 and Diagnostic Value of Serum miRNA let-7a Level in pancreatic cancer].
Mao XB; Sheng T; Zhuang LP; Wu CK; Zhao GG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):540-545. PubMed ID: 32691564
[TBL] [Abstract] [Full Text] [Related]
15. pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.
Franses JW; Philipp J; Missios P; Bhan I; Liu A; Yashaswini C; Tai E; Zhu H; Ligorio M; Nicholson B; Tassoni EM; Desai N; Kulkarni AS; Szabolcs A; Hong TS; Liss AS; Fernandez-Del Castillo C; Ryan DP; Maheswaran S; Haber DA; Daley GQ; Ting DT
Nat Commun; 2020 Jul; 11(1):3303. PubMed ID: 32620742
[TBL] [Abstract] [Full Text] [Related]
16. MiR-590 Suppresses Proliferation and Induces Apoptosis in pancreatic cancer by Targeting High Mobility Group A2.
Wang YD; Mao JD; Wang JF; Xu MQ
Technol Cancer Res Treat; 2020; 19():1533033820928143. PubMed ID: 32588766
[TBL] [Abstract] [Full Text] [Related]
17. High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN.
Guo HH; Wang YZ; Zhang ZK; Li MZ; Tian XD; Yang YM
Exp Cell Res; 2020 Aug; 393(1):112088. PubMed ID: 32413362
[TBL] [Abstract] [Full Text] [Related]
18. Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer.
Jiang MJ; Chen YY; Dai JJ; Gu DN; Mei Z; Liu FR; Huang Q; Tian L
Mol Cancer; 2020 Mar; 19(1):68. PubMed ID: 32228703
[TBL] [Abstract] [Full Text] [Related]
19. OLR1 Promotes pancreatic cancer Metastasis via Increased c-Myc Expression and Transcription of hmga2.
Yang G; Xiong G; Feng M; Zhao F; Qiu J; Liu Y; Cao Z; Wang H; Yang J; You L; Zheng L; Zhang T; Zhao Y
Mol Cancer Res; 2020 May; 18(5):685-697. PubMed ID: 32019809
[TBL] [Abstract] [Full Text] [Related]
20. MiR-497 inhibits cell proliferation and invasion ability by targeting hmga2 in pancreatic ductal adenocarcinoma.
Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
[TBL] [Abstract] [Full Text] [Related]
[Next]
